The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
